Ducasa N, Grasso D, Benencio P, Papademetrio D, Biglione M, Kashanchi F
Front Oncol. 2021; 11:641269.
PMID: 33869030
PMC: 8045967.
DOI: 10.3389/fonc.2021.641269.
Zonouz T, Abdulbaki R, Bandyopadhyay B, Nava V
Curr Oncol. 2021; 28(1):818-824.
PMID: 33562071
PMC: 7985755.
DOI: 10.3390/curroncol28010079.
Tabrizi S, Gholampour M, Zarmehri A, Sadeghian M, Keramati M
Niger Med J. 2020; 61(3):151-155.
PMID: 33100467
PMC: 7547752.
DOI: 10.4103/nmj.NMJ_127_19.
Georgieva E
Int J Mol Sci. 2018; 19(11).
PMID: 30413005
PMC: 6274929.
DOI: 10.3390/ijms19113508.
Ichikawa A, Miyoshi H, Arakawa F, Kiyasu J, Sato K, Niino D
Oncol Lett. 2017; 13(6):4611-4618.
PMID: 28599462
PMC: 5453040.
DOI: 10.3892/ol.2017.6067.
Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.
Bellon M, Lu L, Nicot C
Blood. 2016; 127(20):2439-50.
PMID: 26813676
PMC: 4874225.
DOI: 10.1182/blood-2015-11-685032.
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G, Abdallah R, Accolla R, Tosi G
J Virol. 2016; 90(7):3708-21.
PMID: 26792751
PMC: 4794681.
DOI: 10.1128/JVI.03000-15.
Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D, Ramos J, Barber G
J Virol. 2015; 89(23):11786-800.
PMID: 26378177
PMC: 4645320.
DOI: 10.1128/JVI.01356-15.
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
Pujari R, Hunte R, Thomas R, van der Weyden L, Rauch D, Ratner L
PLoS Pathog. 2015; 11(3):e1004721.
PMID: 25774694
PMC: 4361615.
DOI: 10.1371/journal.ppat.1004721.
Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.
Yari A, Rezaee S, Valizadeh N, Rajaee T, Jazayeri S, Soltani M
Iran J Basic Med Sci. 2014; 17(7):531-6.
PMID: 25429345
PMC: 4242924.
Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.
Larocque E, Andre-Arpin C, Borowiak M, Lemay G, Switzer W, Duc Dodon M
J Virol. 2014; 88(16):8956-70.
PMID: 24872589
PMC: 4136272.
DOI: 10.1128/JVI.01094-14.
In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.
Sagar D, Masih S, Schell T, Jacobson S, Comber J, Philip R
Vaccine. 2014; 32(26):3274-84.
PMID: 24739247
PMC: 4044917.
DOI: 10.1016/j.vaccine.2014.03.087.
Highlights on distinctive structural and functional properties of HTLV Tax proteins.
Romanelli M, Diani E, Bergamo E, Casoli C, Ciminale V, Bex F
Front Microbiol. 2013; 4:271.
PMID: 24058363
PMC: 3766827.
DOI: 10.3389/fmicb.2013.00271.
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G, Abdallah R, Accolla R, Tosi G
Front Microbiol. 2013; 4:234.
PMID: 23986750
PMC: 3749491.
DOI: 10.3389/fmicb.2013.00234.
Animal models on HTLV-1 and related viruses: what did we learn?.
El Hajj H, Nasr R, Kfoury Y, Dassouki Z, Nasser R, Kchour G
Front Microbiol. 2012; 3:333.
PMID: 23049525
PMC: 3448133.
DOI: 10.3389/fmicb.2012.00333.
HTLV-1 Rex: the courier of viral messages making use of the host vehicle.
Nakano K, Watanabe T
Front Microbiol. 2012; 3:330.
PMID: 22973269
PMC: 3434621.
DOI: 10.3389/fmicb.2012.00330.
New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.
Cheng H, Ren T, Sun S
Protein Cell. 2012; 3(8):581-9.
PMID: 22865346
PMC: 3553852.
DOI: 10.1007/s13238-012-2047-0.
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.
Lairmore M, Anupam R, Bowden N, Haines R, Haynes 2nd R, Ratner L
Viruses. 2011; 3(7):1131-65.
PMID: 21994774
PMC: 3185783.
DOI: 10.3390/v3071131.
Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.
Edwards D, Fenizia C, Gold H, de Castro-Amarante M, Buchmann C, Pise-Masison C
Viruses. 2011; 3(6):861-85.
PMID: 21994758
PMC: 3185781.
DOI: 10.3390/v3060861.
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?.
Nasr R, El Hajj H, Kfoury Y, de The H, Hermine O, Bazarbachi A
Viruses. 2011; 3(6):750-69.
PMID: 21994752
PMC: 3185778.
DOI: 10.3390/v3060750.
